IDH2 p.R172 mutation Predicts Superior Outcomes in IDH-mutated Acute Myeloid Leukemia or Myelodysplastic Syndrome patients undergoing Allogeneic Hematopoietic Cell Transplantation: a retrospective study from the Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH-TC)
Authors:
- Ana Pérez-GonzálezAPAna Pérez-González
- Víctor NavarroVíctor Navarro
- Manuel GuerreiroManuel Guerreiro
- Marta VillalbaMarta Villalba
- Alejandro AvendañoAAAlejandro Avendaño
- Estefanía Pérez-LópezEPEstefanía Pérez-López
- Ana Pilar González-RodríguezAna Pilar González-Rodríguez
- Alberto MussettiAlberto Mussetti
- Rocío ParodyRPRocío Parody
- Mi KwonMi Kwon
- Irene García-CadenasIrene García-Cadenas
- Teresa ZudaireTZTeresa Zudaire
- 29 October 2026
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International ConsortiumTransplantation and Cellular Therapy, 2016
- Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group ReportTransplantation and Cellular Therapy, 2015
- Characteristics, clinical outcome, and prognostic significance of IDH mutations in AMLAmerican Journal of Hematology, 2015
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2015
- Prognostic significance of alterations in IDH enzyme isoforms in patients with AML treated with high‐dose cytarabine and idarubicinCancer, 2011
- Role of Allogeneic Transplantation for FLT3/ITD Acute Myeloid Leukemia: Outcomes from 133 Consecutive Newly Diagnosed Patients from a Single InstitutionTransplantation and Cellular Therapy, 2011
- Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete RemissionJAMA, 2009
- Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group ReportTransplantation and Cellular Therapy, 2006
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2005
- Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remissionCancer, 2005